Comet Lithium Corporation
XTRRF
$0.13
$0.0330.00%
| Weiss Ratings | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -6.54 | |||
| Price History | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 20.37% | |||
| 90-Day Total Return | -39.53% | |||
| Year to Date Total Return | 20.37% | |||
| 1-Year Total Return | -51.26% | |||
| 2-Year Total Return | -79.35% | |||
| 3-Year Total Return | -33.81% | |||
| 5-Year Total Return | -65.61% | |||
| 52-Week High % Change | -46.28% | |||
| 52-Week Low % Change | 30.00% | |||
| Price | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.24 | |||
| 52-Week Low Price | $0.10 | |||
| 52-Week Low Price (Date) | Jan 31, 2025 | |||
| 52-Week High Price (Date) | May 21, 2024 | |||
| Valuation | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.41M | |||
| Enterprise Value | 2.60M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.10 | |||
| Earnings Per Share Growth | 135.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.70 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.13 | |||
| Enterprise Value/EBITDA (TTM) | -1.61 | |||
| Enterprise Value/EBIT | -1.27 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 25.83M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 819 762 4101 | |||
| Address | 147 QuEbec Avenue (back door) Rouyn-Noranda, QC J9X 6M8 | |||
| Website | cometlithium.com | |||
| Country | Canada | |||
| Year Founded | 2013 | |||
| Profitability | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -30.31% | |||
| Return on Equity | -- | |||
| Income Statement | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -1.97M | |||
| EBIT (TTM) | -2.48M | |||
| Net Income (TTM) | -2.08M | |||
| Net Income Avl. to Common (TTM) | -2.08M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 43.97% | |||
| EPS Diluted (TTM) | -0.10 | |||
| EPS Diluted Growth (Q YOY) | 0.00% | |||
| Balance Sheet | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 859.00K | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 1.20M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.95M | |||
| Current Ratio (Q) | 2.736 | |||
| Book Value Per Share (Q) | $0.19 | |||
| Total Assets (Q) | 5.39M | |||
| Total Current Liabilities (Q) | 439.30K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 439.30K | |||
| Total Common Equity (Q) | 4.95M | |||
| Cash Flow | XTRRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.46M | |||
| Cash from Financing (TTM) | 1.84M | |||
| Net Change in Cash (TTM) | 127.10K | |||
| Levered Free Cash Flow (TTM) | -1.00M | |||
| Cash from Operations (TTM) | -251.40K | |||
